Rubius Therapeutics Inc (OTC Pink - Limited Information:RUBY)
| 0.0204 Delayed Data As of May 26 |  +0.0031 / +17.92%Today’s Change | 0.01 Today|||52-Week Range 1.57 | -88.34% Year-to-Date |
Latest RUBY News | Press Releases
No recent news for Rubius Therapeutics Inc.
Today’s Trading
| Previous close | 0.02 |
| Today’s open | 0.02 |
| Day’s range | 0.02 - 0.02 |
| Volume | 57,661 |
| Average volume (3 months) | 2,715,164 |
| Market cap | $1.8M |
Data as of 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +10.98% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 0.12 |
Competitors
| No competitors data available. |
Financials
| Last reporting date | November 16, 2022 |
| EPS forecast (this quarter) | -$0.42 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$179.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Foxboro, Massachusetts |
Forecasts
Chart unavailable
